Page last updated: 2024-10-27

gemfibrozil and Palmoplantaris Pustulosis

gemfibrozil has been researched along with Palmoplantaris Pustulosis in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Gemfibrozil or placebo was given in a double-blind cross-over fashion to 14 patients, who after 8 weeks of acitretin therapy and dietary advice exhibited hyperlipidemia (triglyceride levels > or = 50% above baseline and/or > or = 2."2.68Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study. ( Lindholm, A; Olsson, AG; Vahlquist, A; Vahlquist, C, 1995)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vahlquist, C1
Olsson, AG1
Lindholm, A1
Vahlquist, A1
Frick, MH1
Fisher, DA1
Elias, PM1
LeBoit, PL1

Trials

1 trial available for gemfibrozil and Palmoplantaris Pustulosis

ArticleYear
Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Acta dermato-venereologica, 1995, Volume: 75, Issue:5

    Topics: Acitretin; Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dose-Re

1995

Other Studies

2 other studies available for gemfibrozil and Palmoplantaris Pustulosis

ArticleYear
Exacerbation of psoriasis.
    Archives of dermatology, 1989, Volume: 125, Issue:1

    Topics: Gemfibrozil; Humans; Male; Middle Aged; Psoriasis

1989
Exacerbation of psoriasis by the hypolipidemic agent, gemfibrozil.
    Archives of dermatology, 1988, Volume: 124, Issue:6

    Topics: Female; Gemfibrozil; Humans; Hypolipidemic Agents; Middle Aged; Pentanoic Acids; Psoriasis; Valerate

1988